Share on StockTwits

Illumina (NASDAQ:ILMN) SVP Mostafa Ronaghi sold 10,000 shares of Illumina stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $156.93, for a total transaction of $1,569,300.00. Following the completion of the transaction, the senior vice president now directly owns 28,604 shares in the company, valued at approximately $4,488,826. The sale was disclosed in a legal filing with the SEC, which is available at this link.

A number of research firms have recently commented on ILMN. Analysts at Ned Davis Research upgraded shares of Illumina from a “sell” rating to a “neutral” rating in a research note on Monday, April 28th. Separately, analysts at Maxim Group upgraded shares of Illumina from a “hold” rating to a “buy” rating in a research note on Wednesday, April 23rd. They now have a $205.00 price target on the stock. Finally, analysts at Bank of America reiterated a “buy” rating on shares of Illumina in a research note on Wednesday, April 23rd. They now have a $195.00 price target on the stock. Eight investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Illumina has an average rating of “Buy” and an average target price of $144.34.

Shares of Illumina (NASDAQ:ILMN) traded up 0.57% during mid-day trading on Tuesday, hitting $159.58. 1,136,406 shares of the company’s stock traded hands. Illumina has a 1-year low of $66.11 and a 1-year high of $183.30. The stock has a 50-day moving average of $145.6 and a 200-day moving average of $137.7. The company has a market cap of $20.490 billion and a P/E ratio of 111.59. Illumina also was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 17,710,485 shares, a decline of 11.9% from the April 30th total of 20,100,661 shares. Approximately 14.0% of the shares of the company are short sold. Based on an average daily volume of 1,263,753 shares, the short-interest ratio is presently 14.0 days.

Illumina (NASDAQ:ILMN) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $0.46 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.01. The company had revenue of $421.00 million for the quarter, compared to the consensus estimate of $391.50 million. During the same quarter in the previous year, the company posted $0.46 earnings per share. The company’s revenue for the quarter was up 27.2% on a year-over-year basis. On average, analysts predict that Illumina will post $2.16 earnings per share for the current fiscal year.

Illumina, Inc (NASDAQ:ILMN) is a developer and manufacturer of life science tools and integrated systems for the analysis of genetic variation and function.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.